Novartis researchers are using data to accelerate drug development.

People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.

Improving the patient experience and removing potential barriers to clinical trial participation

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

Novartis researchers are working to extend the life of organ transplants

Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.

Talk to any cancer researcher or doctor today and what you hear is wonder and hope.